early infancy
For Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, the message is clear: how we feed and protect our microbiome determines the clinical outcome.
Maternal oral microbiota plays a key role in influencing infant gut health and disease risk.
Breastfeeding and Bifidobacterium are key factors in shaping the infant resistome and could offer strategies to reduce antibiotic resistance early in life.
Specific gut bacteria are important in early life for healthy immune development.
Bacterial metabolites such as inosine could be used as a therapy to strengthen infant immunity after early microbiota disruption.
Professor Ruggiero Francavilla, pediatric gastroenterologist at the Polyclinic of Bari (Italy), offers a preview of his upcoming talk at the 10th International Congress of Probiotics, Prebiotics, and Postbiotics in Pediatrics.
Tracking the oral microbiota can help identify ECC risk early and inform prevention strategies in children, even before visible signs of decay.
Professor Flavia Indrio, President of the 10th International Congress on Probiotics, Prebiotics, and Postbiotics in Pediatrics, previews the key topics for the upcoming 2026 event in Lecce, April 16-18.
A microbiota-mediated macrophage-dependent mechanism may be used to reduce diabetes incidence in vivo.
The findings of a recent study highlight the importance of early-life gut microbes in shaping lung health and add to evidence that microbiota composition can influence asthma risk.
